View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
 PRESS RELEASE

Tandy Leather Factory Reports First Quarter 2024 Results

Tandy Leather Factory Reports First Quarter 2024 Results FORT WORTH, Texas, May 10, 2024 (GLOBE NEWSWIRE) -- Tandy Leather Factory, Inc. (Nasdaq: TLF) today announced the Company’s financial results for the first fiscal quarter of 2024. Highlights from First Quarter 2024: Revenues were $19.3 million, down 5.3% from 2023Generated operating income of $0.7 millionNet income of $0.5 million, down from $0.7 million in 2023Gross margins of 56.7%, down from 58.1% in 2023Operating expenses $10.3 million, down 5.2% from 2023Adjusted EBITDA* of $1.1 millionEnded quarter with $12.3 million...

 PRESS RELEASE

Albany International Declares Dividend

ROCHESTER, N.H.--(BUSINESS WIRE)-- The Board of Directors of Albany International Corp. (NYSE: AIN) today declared a quarterly dividend of $0.26 per share on the Company’s Class A Common Stock. The dividend is payable July 8, 2024, to shareholders of record on June 7, 2024. About Albany International Corp. Albany International is a leading developer and manufacturer of engineered components, using advanced materials processing and automation capabilities, with two core businesses. Machine Clothing is the world’s leading producer of custom-designed, consumable belts essential for the m...

 PRESS RELEASE

CPS Announces First Quarter 2024 Earnings

CPS Announces First Quarter 2024 Earnings Revenues of $91.7 million compared to $83.1 million in the prior year periodPretax income of $6.6 millionNet income of $4.6 million, or $0.19 per diluted shareNew contract purchases of $346.3 million LAS VEGAS, NV, May 10, 2024 (GLOBE NEWSWIRE) -- Consumer Portfolio Services, Inc. (Nasdaq: CPSS) (“CPS” or the “Company”) today announced earnings of $4.6 million, or $0.19 per diluted share, for its first quarter ended March 31, 2024. This compares to a net income of $13.8 million, or $0.54 per diluted share, in the first quarter of 2023. R...

 PRESS RELEASE

Apollo Tactical Income Fund Inc. Declares May 2024 Monthly Distributio...

Apollo Tactical Income Fund Inc. Declares May 2024 Monthly Distribution of $0.144 Per Share NEW YORK, May 10, 2024 (GLOBE NEWSWIRE) -- (NYSE: AIF) - Apollo Tactical Income Fund Inc. (the “Fund”) today announced the declaration of its distribution for the month of May 2024 of $0.144 per common share, payable on the date noted below. The following dates apply to the declared distribution: Ex-Date: May 22, 2024Record Date: May 23, 2024Payment Date: May 31, 2024Per Share Amount: $0.144 Apollo Contact Information: Product Literature877-864-4834 InvestorsElizabeth BesenInvestor Relations M...

 PRESS RELEASE

Apollo Senior Floating Rate Fund Inc. Declares May 2024 Monthly Distri...

Apollo Senior Floating Rate Fund Inc. Declares May 2024 Monthly Distribution of $0.140 Per Share NEW YORK, May 10, 2024 (GLOBE NEWSWIRE) -- (NYSE: AFT) - Apollo Senior Floating Rate Fund Inc. (the “Fund”) today announced the declaration of its distribution for the month of May 2024 of $0.140 per common share, payable on the date noted below. The following dates apply to the declared distribution: Ex-Date: May 22, 2024Record Date: May 23, 2024Payment Date: May 31, 2024Per Share Amount: $0.140 Apollo Contact Information: Product Literature877-864-4834 InvestorsElizabeth BesenInvestor R...

 PRESS RELEASE

KULR Technology Group Sets First Quarter 2024 Earnings Call for Wednes...

KULR Technology Group Sets First Quarter 2024 Earnings Call for Wednesday, May 15, 2024 at 4:30 p.m. ET SAN DIEGO, May 10, 2024 (GLOBE NEWSWIRE) -- (NYSE American: KULR) (the "Company" or "KULR"), a global leader in sustainable energy management, will hold a conference call on Wednesday, May 15th at 4:30 p.m. Eastern time (1:30 p.m. Pacific time) to discuss its financial results for the first quarter ended March 31, 2024. The financial results will be issued in a press release prior to the call. KULR management will host the conference call, followed by a question-and-answer period. Int...

 PRESS RELEASE

Navios Maritime Partners L.P. Announces the Date for the Release of Fi...

Navios Maritime Partners L.P. Announces the Date for the Release of First Quarter Ended March 31, 2024 Results, Conference Call and Webcast Conference Call & Webcast: Tuesday, May 14, 2024 at 8:30 am ET MONACO, May 10, 2024 (GLOBE NEWSWIRE) -- Navios Maritime Partners L.P. ("Navios Partners") (NYSE:NMM) announced today that it will host a conference call on Tuesday, May 14, 2024 at 8:30 am ET, at which time Navios Partners' senior management will provide highlights and commentary on earnings results for the first quarter ended March 31, 2024. The Company will report results for the firs...

 PRESS RELEASE

FutureFuel Releases First Quarter 2024 Results

FutureFuel Releases First Quarter 2024 Results Reports Net Income of $4.3 Million or $0.10 per Diluted Share, and Adjusted EBITDA of $7.1 Million CLAYTON, Mo., May 10, 2024 (GLOBE NEWSWIRE) -- FutureFuel Corp. (NYSE: FF) (“FutureFuel”), a manufacturer of custom and performance chemicals and biofuels, today announced financial results for the first quarter ended March 31, 2024. First quarter 2024 Financial Highlights (all comparisons are with the first quarter of 2023) Revenues were $58.3 million, a decrease of 21% or $15.9 million compared to $74.2 million.Net income was $4.3 million,...

 PRESS RELEASE

Entera Bio Reports Q1 2024 Financial Results and Provides Business Upd...

Entera Bio Reports Q1 2024 Financial Results and Provides Business Updates JERUSALEM, May 10, 2024 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX), (“Entera” or the “Company”) a leader in the development of orally delivered peptides and small therapeutic proteins, today reported financial results and key business updates for the quarter ended March 31, 2024. “Entera is off to a strong start in 2024 thanks to the growth strategy we implemented in 2023, expanding our N-Tab™ therapeutic pipeline with potential first in class oral GLP-2, GLP-1/glucagon and PTH(1-34) peptide treatmen...

 PRESS RELEASE

Forward Reports Fiscal 2024 Second Quarter Results

Forward Reports Fiscal 2024 Second Quarter Results HAUPPAUGE, N.Y., May 10, 2024 (GLOBE NEWSWIRE) -- Forward Industries, Inc. (NASDAQ:FORD), a global design, sourcing and distribution group, today announced financial results for its second quarter ended March 31, 2024. Second Quarter Fiscal Year 2024 Financial Highlights    Revenues were $7.8 million, a decrease of 19.6% from $9.7 million for 2023. Gross margin increased to 20.5% compared to 19.8% for 2023.Loss from continuing operations was $0.5 million compared to $0.1 million in 2023 and net loss was $0.6 million compared to $0.9 m...

 PRESS RELEASE

Atrion Reports First Quarter 2024 Results

Atrion Reports First Quarter 2024 Results ALLEN, Texas, May 10, 2024 (GLOBE NEWSWIRE) -- Atrion Corporation (NASDAQ: ATRI) today announced its results for the first quarter ended March 31, 2024. Revenues for the first quarter of 2024 totaled $47.3 million compared to $40.0 million for the same period in 2023. For the just ended quarter, operating income was $3.1 million, down $1.3 million from the comparable 2023 period, primarily due to a one-time inventory write-off, and net income was $2.8 million, down $0.7 million from the same period in 2023. First quarter 2024 diluted earnings per...

Moody's Ratings downgrades Zumbrota-Mazeppa ISD 2805, MN's issuer rati...

Moody's Ratings (Moody's) has downgraded Zumbrota-Mazeppa Independent School District 2805, MN's issuer rating and outstanding general obligation unlimited tax (GOULT) rating to A2 from A1. As of fiscal year-end 2023 (June 30th), the district had approximately $47 million in debt outstanding. The ...

 PRESS RELEASE

Ocugen Announces Distribution of Series C Preferred Stock to Holders o...

Ocugen Announces Distribution of Series C Preferred Stock to Holders of its Common Stock MALVERN, Pa., May 10, 2024 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines, today announced that its Board of Directors declared a dividend of one one-thousandth of a share of newly designated Series C Preferred Stock, par value $0.01 per share, for each outstanding share of the Company’s common stock held of record as of 5:00 p.m. Eastern Time on May 20, ...

 PRESS RELEASE

Longeveron Announces Board of Directors Planned Transitions

Longeveron Announces Board of Directors Planned Transitions Richard Kender, retired SVP of Business Development and Corporate Licensing for Merck & Co., Inc., has been appointed to the Longeveron BoardDr. Roger Hajjar, former head of R&D at Ring Therapeutics, has been nominated as a candidate for the Board, subject to election at the Company’s Annual Meeting of StockholdersNeha Motwani, former managing director and senior healthcare investment banker at William Blair, Truist, and Oppenheimer and Company, also has been nominated as a candidate for the Board, subject to election at the Compan...

 PRESS RELEASE

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)...

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) MALVERN, Pa., May 10, 2024 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced that the Compensation Committee of the Board of Directors of TELA Bio approved inducement grants of restricted stock units covering 20,250 shares of its common stock to eleven newly-hired employees, with a grant date of May 6, 2024 (the "Grant Date"). The restricted stock units were granted pursua...

 PRESS RELEASE

89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) SAN FRANCISCO, May 10, 2024 (GLOBE NEWSWIRE) -- 89bio, Inc. (the “Company” or “89bio”) (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardiometabolic diseases, today announced that the Compensation Committee of the Company’s Board of Directors approved the grant of non-qualified stock options to purchase an aggregate of 48,150 shares of the Company’s common stock to four new employees (the “Inducement Gra...

 PRESS RELEASE

RLI Names Deb Millum as Vice President, Claim

PEORIA, Ill.--(BUSINESS WIRE)-- RLI Corp. (NYSE: RLI) -- RLI Corp. announced today the promotion of Deb Millum to Vice President, Claim. In her new role, Millum will assume executive leadership and oversight responsibility for RLI’s Transportation, Non-Transportation Auto and Personal Umbrella product claims. Millum joined RLI in 2017 as Director, Claim Counsel and was promoted to Assistant Vice President, Claim Counsel in 2019. She brings nearly 30 years of insurance claim and legal experience to her new role. Millum holds a Juris Doctorate degree from the University of Dayton School of Law...

 PRESS RELEASE

Cassava Sciences Reports Q1 2024 Financial Results and Clinical Update...

Cassava Sciences Reports Q1 2024 Financial Results and Clinical Updates on Phase 3 Trials of Simufilam $126.3 Million In Total Gross Proceeds from Warrant Distribution.Over 1,900 Patients with Alzheimer’s Disease Are Randomized in Phase 3 Trials of Simufilam.Over 735 Patients Have Completed a Phase 3 Trial of Simufilam. AUSTIN, Texas, May 10, 2024 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc. (Nasdaq: SAVA), a biotechnology company focused on Alzheimer’s disease, today reported financial results for first quarter ended March 31, 2024. Net income was $25.0 million compared to a net loss o...

 PRESS RELEASE

Senvest Capital Inc. Reports Results for the First Quarter Ended March...

Senvest Capital Inc. Reports Results for the First Quarter Ended March 31, 2024 MONTREAL, May 10, 2024 (GLOBE NEWSWIRE) -- Senvest Capital Inc. today reported net income attributable to common shareholders of $52.3 million or $21.17 per share for the three months ended March 31, 2024. This compares to net income attributable to common shareholders of $43.8 million or $17.66 per share for the same period in 2023 Financial statements are available online at Sedar+  CONSOLIDATED STATEMENTS OF INCOME  (unaudited) (in millions of dollars, except per share amounts) For the three months ended ...

 PRESS RELEASE

Senvest Capital Inc. annonce ses résultats pour le trimestre terminé l...

Senvest Capital Inc. annonce ses résultats pour le trimestre terminé le 31 mars 2024 MONTRĖAL, 10 mai 2024 (GLOBE NEWSWIRE) -- Senvest Capital Inc. a annoncé aujourd’hui un résultat net attribuable aux actionnaires ordinaires de 52,3 M$ ou 21,17 $ par action pour les trois mois terminés le 31 mars 2024. Pour la période correspondante de 2023, elle avait inscrit un résultat net attribuable aux actionnaires ordinaires de 43,8 M$ ou 17,66 $ par action.   Les états financiers sont disponibles sur le site Sedar+  ÉTAT CONSOLIDÉ DES RÉSULTATS (non vérifié) (en millions de dollars, sauf les...

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch